IL328897A - תצמיד אנטי-ויראלי - Google Patents

תצמיד אנטי-ויראלי

Info

Publication number
IL328897A
IL328897A IL328897A IL32889726A IL328897A IL 328897 A IL328897 A IL 328897A IL 328897 A IL328897 A IL 328897A IL 32889726 A IL32889726 A IL 32889726A IL 328897 A IL328897 A IL 328897A
Authority
IL
Israel
Prior art keywords
antiviral conjugate
antiviral
conjugate
Prior art date
Application number
IL328897A
Other languages
English (en)
Original Assignee
Suzhou Renolynx Therapeutics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Renolynx Therapeutics Co Ltd filed Critical Suzhou Renolynx Therapeutics Co Ltd
Publication of IL328897A publication Critical patent/IL328897A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL328897A 2023-12-08 2024-12-06 תצמיד אנטי-ויראלי IL328897A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202311676711 2023-12-08
CN202411063815 2024-08-05
PCT/CN2024/137478 WO2025119337A1 (zh) 2023-12-08 2024-12-06 一种抗病毒偶联物

Publications (1)

Publication Number Publication Date
IL328897A true IL328897A (he) 2026-08-01

Family

ID=95980611

Family Applications (1)

Application Number Title Priority Date Filing Date
IL328897A IL328897A (he) 2023-12-08 2024-12-06 תצמיד אנטי-ויראלי

Country Status (6)

Country Link
CN (1) CN121969399A (he)
AU (1) AU2024393129A1 (he)
CO (1) CO2026009941A2 (he)
IL (1) IL328897A (he)
TW (1) TW202527994A (he)
WO (1) WO2025119337A1 (he)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287153A1 (en) 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
CN104877127B (zh) * 2015-06-23 2017-11-10 厦门赛诺邦格生物科技股份有限公司 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质
BR112020020307A2 (pt) 2018-04-04 2021-01-12 Arvinas Operations, Inc. Moduladores de proteólise e métodos de uso associados
KR20210079278A (ko) * 2018-09-06 2021-06-29 시다라 세라퓨틱스, 인코포레이티드 바이러스 감염의 치료를 위한 조성물 및 방법
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法
US20210230248A1 (en) * 2020-01-25 2021-07-29 Jun Chen Multivalent pharmacophores for high avidity and overexpressed-target specific binding and uses thereof
CN116367866A (zh) * 2020-08-06 2023-06-30 奇达拉治疗公司 蛋白质-药物偶联物的合成方法
WO2022192685A1 (en) * 2021-03-11 2022-09-15 Cidara Therapeutics, Inc. Protein-drug conjugates for antiviral therapy
CN118678970A (zh) * 2021-12-30 2024-09-20 苏州爱科百发生物医药技术有限公司 用于预防和治疗病毒感染的偶联物及其用途

Also Published As

Publication number Publication date
WO2025119337A1 (zh) 2025-06-12
CO2026009941A2 (es) 2026-07-21
CN121969399A (zh) 2026-05-01
AU2024393129A1 (en) 2026-07-23
TW202527994A (zh) 2025-07-16